GMP Factory Supply Orforglipron Powder; CAS 2212020-52-3
27 Inquiries
2212020-52-3
Pharmaceutical Grade
99%
Shanghai
TNV Biochem
Customizable
2025-11-10
Sematlutide,Tirzepatide,Retatrutide; NAD+; SNAC;Salcaprozate sodium ;Custom synthesis
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Orforglipron
Other Name:1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy...;LY3502970;GLP-1 receptor agonist 1 USP/EP/BP;Orforglipron;Orforglipron（LY3502970）;LY3502970 (Orforglipron);3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one;OWL 833
CAS No.:2212020-52-3
Molecular Formula:C48H48F2N10O5
InChIKeys:USUWIEBBBWHKNI-BBGRWQLENA-N
Molecular Weight:882.97
EC Number:278-636-5
Color/Form:Off-white to light yellow
Categories:
Characteristics-
Density:
1.50±0.1 g/cm3(Predicted)
PKA:7.33±0.20(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Sematlutide,Tirzepatide,Retatrutide; NAD+; SNAC;Salcaprozate sodium ;Custom synthesis
-
Location:
Room 3, 1103, No. 42, Tianhu Road
-
Payment Terms:
TT against copy of documents,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
300
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2024
-
-
Inquiry History27 Inquiries
Country Product Purchase Quantity Date Posted 
Bulgaria
orforglipron
1 KG Aug 27, 2025 
United States
Orforglipron
190 MT Jun 20, 2026 
Austria
Orforglipron
1000 MT Jun 12, 2026 
Switzerland
Orforglipron
10 MG Apr 25, 2026
United States
Orforglipron
20 G Apr 3, 2026
United States
Orforglipron
10 G Mar 29, 2026
United States
oforglipron
3 KG Jul 4, 2025 
Belgium
Orforglipron
1 G Jun 14, 2026 
Puerto Rico
Orforglipron
1 G Mar 2, 2026
United States
Orforglipron
10 G Oct 24, 2025
United States
Orforglipron
1 G Sep 30, 2025
United States
Orforglipron
1 G Sep 26, 2025
United States
Orforglipron
1 G Sep 26, 2025
United States
orforglipron
1 MT Sep 20, 2025
United States
Orforglipron
1 KG Apr 18, 2025 
Canada
LY-3502970
10 G Feb 26, 2026
United States
Orforglipron
200 PCS Jun 18, 2026
United States
orforglipron
10 G Apr 20, 2026
United States
Orforglipron
10 G Apr 6, 2026
United States
orforglipron
1 G Mar 24, 2026 Post an enquiry for this product
